GenSight Biologics S.A. (EPA:SIGHT)
0.0837
-0.0037 (-4.23%)
Oct 2, 2026, 5:35 PM CET
GenSight Biologics Employees
GenSight Biologics had 13 employees as of December 31, 2025. The number of employees decreased by 3 or -18.75% compared to the previous year.
Employees
13
Change (1Y)
-3
Growth (1Y)
-18.75%
Revenue / Employee
€-19,308
Profits / Employee
€1,180,000
Market Cap
19.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 13 | -3 | -18.75% | 13 | 0 |
| Dec 31, 2024 | 16 | 0 | - | 16 | 0 |
| Dec 31, 2023 | 16 | -29 | -64.44% | 16 | 0 |
| Dec 31, 2022 | 45 | 7 | 18.42% | 45 | 0 |
| Dec 31, 2021 | 38 | 13 | 52.00% | 38 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| genOway Société anonyme | 157 |
| Adocia | 73 |
| Fermentalg | 64 |
| MaaT Pharma | 59 |
| Biophytis | 19 |
| Aelis Farma | 16 |
| Aton | 13 |
| TME Pharma | 12 |
GenSight Biologics News
- 3 days ago - GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates - Business Wire
- 3 days ago - GenSight Biologics Quarterly report: H1 2026 - Filings
- 3 days ago - GenSight Biologics Earnings release: H1 2026 - Filings
- 24 days ago - GenSight Biologics Provides Business Update, Sets Results Date; Stock Up - Nasdaq
- 24 days ago - GenSight Biologics Provides September 2026 Business Updates - Business Wire
- 2 months ago - GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates - Business Wire
- 4 months ago - GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026 - Business Wire
- 4 months ago - GenSight Biologics to Hold its Combined General Meeting on May 19, 2026 - Business Wire